MSIL, Zydus Hospitals tie up for health centre

Ahmedabad: To provide quality healthcare at affordable prices, Maruti Suzuki India Limited (MSIL) has tied-up with Zydus Hospitals to set up a modern polyclinic (health centre) facility at Becharaji near Mehsana.

“Residents of Becharaji and its neighbouring areas need access to quality healthcare at affordable rates. Maruti Suzuki has taken a first step by setting up a polyclinic to offer primary health and diagnostic services,” said MSIL managing director Kenichi Ayukawa, who, along with Zydus Hospitals’ founder chairman Pankaj Patel, inaugurated the facility on Wednesday.

Equipped with advanced diagnostics equipment, the centre will offer facilities such as x-ray, a TMT machine, ECG, pathology laboratory, ultrasound, ambulance and a pharmacy, among others.

The facility will be managed and operated by Ramanbhai Foundation through Zydus Hospitals, a leading healthcare services provider. The centre will be fully funded by MSIL, through its corporate social responsibility (CSR) arm, Maruti Suzuki Foundation.

“Under this CSR initiative, Maruti Suzuki will invest Rs 3.3 crore to set up and fully equip the facility. As services will be offered at subsidized rates, MSIL will bear the cost of maintaining and operating the facility,” the auto giant said in a statement.

Suzuki Motor Corporation (SMC), the parent company of Maruti Suzuki, operates a car manufacturing plant in Becharaji.

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    HC-ordered expert panel for weight loss drug may be set up by mid-July

    HC-ordered expert panel for weight loss drug may be set up by mid-July